Căutare | Friends - Best Social Network - החברים

Devidi Jahnavi a adăugat un sunet Health
2025-07-08 05:15:06

Emerging Vaccines for Ebola: Global Market Overview
What is the projected growth rate (CAGR) of the Ebola *** Vaccine Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Ebola *** Vaccine Market reached US$173.82 million in 2024 and is expected to reach US$288.41 million by 2033, growing at a CAGR of 6.4 % during the forecast period 2025-2033. What is the Ebola *** Vaccine Market? The Ebola *** Vaccine...

0 Commentarii 0 Distribuiri 374 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Devidi Jahnavi a adăugat un sunet Health
2025-07-08 07:47:15

Global Demand for Inactivated Vaccines: Trends and Insights
What is the projected growth rate (CAGR) of the Inactivated Vaccines Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032. What is the Inactivated Vaccines Market? This market...

0 Commentarii 0 Distribuiri 407 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Sindhuri Kotamraju a adăugat un sunet Health
2025-07-18 11:37:11

Inactivated Vaccines Market Share and Future Scope
“Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032”, according to DataM intelligence report. Inactivated vaccines are created by *** the disease-causing microorganisms using heat, chemicals, or radiation. Unlike live vaccines, these do not...

0 Commentarii 0 Distribuiri 298 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Devidi Jahnavi a adăugat un sunet Health
2025-06-23 12:17:24

mRNA Vaccines Redefined: CI Insights into Innovation, Platforms, and Market Expansion
Messenger RNA (mRNA) vaccines have emerged as a transformative force in the global fight against infectious diseases, with their rapid development, adaptability, and precision mechanism driving a new era of preventive medicine. Once considered experimental, mRNA technology now stands at the forefront of vaccine innovation, with expanding applications in infectious disease, oncology, and...

0 Commentarii 0 Distribuiri 776 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Uttej Netha a adăugat un sunet Health
2025-06-27 09:45:32

USDA’s Poultry Vaccine Plan Accelerates USD 12B+ Veterinary Vaccines Industry
The global veterinary vaccines market is entering a phase of sustained growth and innovation, with mounting demand from both companion animal and livestock sectors. According to recent data, market valuation reached USD 12.05 billion in 2024 and is forecast to climb to USD 12.51 billion in 2025 and USD ***56 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.8%. Meanwhile,...

0 Commentarii 0 Distribuiri 870 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Kranthi Reddy a adăugat un sunet Health
2025-06-20 12:27:20

Global Immunization Growth Powers Live Attenuated Vaccine Demand
The Live Attenuated Vaccines Market is experiencing rapid expansion, projected to grow from USD 25.3 billion in 2023 to USD 70.4 billion by 2032. The market is driven by increased demand for robust, long-lasting immunizations, innovations in oral and intranasal delivery systems, and rising infectious disease threats worldwide. Growth is especially strong in the United States, Japan, and across...

0 Commentarii 0 Distribuiri 792 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Uttej Netha a adăugat un sunet Health
2025-06-30 07:33:24

Screening & Awareness Initiatives Bolster Hepatitis B *** Uptake
The global Hepatitis B Treatment Market is positioned for consistent growth, with market valuation expected to increase from USD 4.5 billion in 2023 to USD 7.3 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2024–2032). The rise in chronic hepatitis B cases globally, combined with growing awareness, treatment accessibility, and a strong pipeline of advanced...

0 Commentarii 0 Distribuiri 875 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!